ZBIO logo

ZBIO
Zenas Biopharma Inc.

796
Mkt Cap
$1.11B
Volume
794,013.00
52W High
$44.60
52W Low
$8.51
PE Ratio
-2.29
ZBIO Fundamentals
Price
$19.36
Prev Close
$19.32
Open
$19.23
50D MA
$22.29
Beta
1.45
Avg. Volume
636,908.72
EPS (Annual)
-$8.44
P/B
4.36
Rev/Employee
$59,880.24
$1,360.92
Loading...
Loading...
News
all
press releases
Thursday 4/30 Insider Buying Report: ZBIO, PDX
As the saying goes, there are many possible reasons for an insider to sell a stock, but only one reason to buy -- they expect to make money. So let's look at two noteworthy recent insider buys. At Zenas Biopharma, a filing with the SEC revealed that on Wednesday, Chief Executi...
Nasdaq News: Markets·2d ago
News Placeholder
More News
News Placeholder
Zenas BioPharma (NASDAQ:ZBIO) Shares Gap Up on Insider Buying Activity
Zenas BioPharma (NASDAQ:ZBIO) Shares Gap Up on Insider Buying Activity...
MarketBeat·2d ago
News Placeholder
Leon Moulder, Jr. Buys 25,000 Shares of Zenas BioPharma (NASDAQ:ZBIO) Stock
Zenas BioPharma, Inc. (NASDAQ:ZBIO - Get Free Report) CEO Leon Moulder, Jr. purchased 25,000 shares of the company's stock in a transaction that occurred on Tuesday, April 28th. The shares were...
MarketBeat·2d ago
News Placeholder
Zenas BioPharma (NASDAQ:ZBIO) CEO Acquires $616,700.00 in Stock
Zenas BioPharma, Inc. (NASDAQ:ZBIO - Get Free Report) CEO Leon Moulder, Jr. bought 35,000 shares of the stock in a transaction on Wednesday, April 29th. The stock was purchased at an average cost of...
MarketBeat·3d ago
News Placeholder
Leon Moulder Jr Purchases 25,000 Shares of Zenas BioPharma (NASDAQ:ZBIO) Stock
Zenas BioPharma, Inc. (NASDAQ:ZBIO - Get Free Report) CEO Leon Moulder, Jr. purchased 25,000 shares of the stock in a transaction that occurred on Tuesday, April 28th. The shares were acquired at an...
MarketBeat·3d ago
News Placeholder
Zenas BioPharma, Inc. (NASDAQ:ZBIO) Given Average Rating of "Hold" by Analysts
Zenas BioPharma, Inc. (NASDAQ:ZBIO - Get Free Report) has been given an average rating of "Hold" by the nine brokerages that are presently covering the firm, Marketbeat reports. Two investment...
MarketBeat·12d ago
News Placeholder
Zenas BioPharma (NASDAQ:ZBIO) Issues Quarterly Earnings Results
Zenas BioPharma (NASDAQ:ZBIO - Get Free Report) posted its earnings results on Monday. The company reported ($1.10) earnings per share (EPS) for the quarter...
MarketBeat·18d ago
News Placeholder
Zenas BioPharma (NASDAQ:ZBIO) Shares Down 7% - Should You Sell?
Zenas BioPharma (NASDAQ:ZBIO) Shares Down 7% - Should You Sell...
MarketBeat·24d ago
News Placeholder
Fairmount Funds Management Llc Acquires 150,000 Shares of Zenas BioPharma (NASDAQ:ZBIO) Stock
Zenas BioPharma, Inc. (NASDAQ:ZBIO - Get Free Report) Director Fairmount Funds Management Llc purchased 150,000 shares of the stock in a transaction on Tuesday, March 31st. The stock was acquired at...
MarketBeat·29d ago
News Placeholder
Insider Buying: Zenas BioPharma (NASDAQ:ZBIO) Director Buys 3,768 Shares of Stock
Zenas BioPharma, Inc. (NASDAQ:ZBIO - Get Free Report) Director Hongbo Lu purchased 3,768 shares of Zenas BioPharma stock in a transaction dated Tuesday, March 31st. The stock was bought at an average price of $18.63 per share, with a total value of $70,197.84. Following the completion of the...
MarketBeat·30d ago
<
1
2
...
>

Latest ZBIO News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.